Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study of Odronextamab in Treatment Naïve Patients With Low Tumor Volume Advanced Stage Follicular Lymphoma

NCT07128641 is registered in ClinicalTrials.gov with Gottfried von Keudell, MD PhD as lead sponsor.

NCT NCT07128641
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07128641 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study of Odronextamab in Treatment Naïve Patients With Low Tumor Volume Advanced Stage Follicular Lymphoma
Lead sponsor
Gottfried von Keudell, MD PhD
Phase
Phase 2
Overall status
Recruiting
Start date
September 8, 2025
Completion date
January 2, 2028
Enrollment
35 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

follicular lymphoma, lymphoma